Fundraising FoxM Ventures — 2026 Investments
6 investments dated 2026 · listed companies and verified rows first · show all
Vizgen develops spatial profiling instruments and reagents for high-throughput analysis of gene expression and protein distribution in tissue samples.
AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US
George Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)inJiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)inRobert Carson(Executive Officer, Director)Terry Lo(Director)inSeth Benson(Executive Officer)inSimona Levi(Executive Officer)in
Co-investorsARCH Venture PartnersNorthpond VenturesIllumina VenturesNovalis LifeSciences
Cyllene Therapeutics is a biotechnology company developing "pinpoint gene therapy" using a non-replicative HSV-1 based vector platform to deliver disease-modifying transgenes for peripheral nervous system disorders.
BiotechDeep TechDigital HealthParis, FR
Philippe Chambon MD, PhD(Founder)inPhilippe Chambon(Founder, Chairman & CEO)Alberto Epstein(Founder & CSO)Cornelia Haag-Molkenteller(CMO)Samuel Salot(COO)Marc Grasso(CFO)
Co-investorsBpifranceSCI VenturesAndera Partners
Future Fertility develops an artificial intelligence tool to assess egg quality for fertility treatment using machine learning analysis of oocyte health.
AI & Machine LearningBiotechDigital HealthFemTechHealthtech
Rene Bharti(Co-founder)inDr. Dan Nayot(Co-founder)
Co-investorsSandpiper VenturesWhitecap Venture PartnersGaingels
__Twitter.png)
Lightcast develops a single-cell functional analysis platform that uses droplet-based technology to profile cell function, biomolecule secretion, cell-cell interactions, and targeted cell killing at scale.
BiotechDeep TechHealthtech
Co-investors+ND CapitalIllumina VenturesLongwall Venture Partners LLPOMX VenturesARCH Venture Partners
Quintessent develops optical connectivity solutions to address chip-to-chip communication bottlenecks in large-scale computing and AI systems.
AI & Machine LearningCloud ComputingDeep TechHardwareSemiconductorsSanta Barbara, US
Alan Liu(CEO, Co-Founder & Board Member)inBrian Koch(VP of Engineering & Co-Founder)inJohn Bowers(Chairman of the Board & Co-Founder)
Co-investorsEntrada VenturesFoothill VenturesOUP (Osage University Partners)Sierra VenturesCycle CapitalIntervest+2 more
STORM Therapeutics is a clinical-stage biotechnology company developing small molecule drugs that target RNA modifying enzymes to reprogram cells through RNA biology.
BiotechHealthtechMedical Devices
Co-investorsCambridge Innovation CapitalFast Track InitiativePfizer Venture InvestmentsSeroba Life SciencesTaiho Ventures, LLCUTokyo Innovation Platform Co. Ltd.+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.